In this pre‐specified, pooled, patient‐level, secondary analysis of the STEP‐HFpEF programme trials, we observed that older participants with obesity‐related HFpEF had a higher burden of comorbidities, lower functional status, lower exercise capacity, and higher NT‐proBNP levels. The gene discussed is NPPB; the disease is obesity disorder.